Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Pharmacovigilance Market Valued at Present and by 2029?

In recent years, the size of the pharmacovigilance market has seen rapid expansion. It is predicted to increase from $8.58 billion in 2024 to $9.64 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.4%. The past growth trend can be traced back to factors such as rising cases of adverse drug reactions (ADRs), heightened research and development (R&D) initiatives, increased rates of drug development, an intensified emphasis on personalized medicine, and a growing occurrence of chronic diseases.

The market size of pharmacovigilance is projected to experience significant expansion in the upcoming years. The market is anticipated to escalate to “$15.5 billion by 2029 with a compound annual growth rate (CAGR) of 12.6%. This predicted growth within the forecast period can be credited to the escalating healthcare costs, additional government assistance, and the aging populace. The forecast period will also witness such major trends as increased investments, utilization of artificial intelligence, the employment of innovative platforms, the incorporation of innovative cloud-based systems, and tactical mergers and acquisitions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

#What Drivers Are Influencing Growth In The Pharmacovigilance Market?

The pharmacovigilance market is being propelled by escalating activities in research and development. As pharmaceutical companies boost their R&D investment, they are better positioned to create innovative, safer drugs. Comprehensive preclinical and clinical evaluations during the drug creation process facilitate the early identification of possible safety risks, enabling the execution of suitable risk reduction strategies. Furthermore, advancements in adverse event observation, data scrutiny, and signal identification technologies aided by R&D efforts enable adverse drug effects to be detected promptly during the post-market phase. For instance, Llywodraeth Cymru Welsh Government, a UK government agency, reported in February 2024 that Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD) in 2022. This accounted for 1.9% of the entire UK expenditure in this field. Consequently, the growth of the pharmacovigilance market has been sustained by the increasing activities in research and development.

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Upcoming Trends Are Expected To Impact The Pharmacovigilance Market Globally?

Pharmaceutical companies in the pharmacovigilance market are turning their attention to artificial intelligence (AI) as a means to enhance efficiency. The use of AI can heighten the precision and effectiveness of pharmacovigilance activities, ultimately resulting in improved patient care. Integration of AI enables pharmaceutical firms to better optimize processes, enhance data management, and fast-track drug finding, all while slashing costs and augmenting safety. For instance, in August 2024, the Indian Government launched the Adverse Drug Reaction Monitoring System (ADRMS) software – a pharmacovigilance software pioneered by the Ministry of Health & Family Welfare and Ministry of Chemicals and Fertilizers. This software makes the process of gathering and interpreting adverse occurrences related to medicines and medical devices easier for consumers and healthcare professionals alike. This move significantly boosts India’s pharmacovigilance framework by assuring a more thorough collection of safety data and improving medication safety monitoring. The ADRMS is designed to enhance the efficiency of drug safety management and adherence to standards, granting India a leadership position in the international pharmaceutical sector.

Which Companies Play A Key Role In The Development Of The Pharmacovigilance Market?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Are The Key Regional Developments Shaping The Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model